Reversal Reaction in A Borderline Lepromatous Leprosy Patient after COVID-19 Vaccine: Prevention or Risks?

Authors

  • Odelia Jovita Jusuf Fantoni Dermatology and Venereology Department, Sriwijaya University, Dr. Moh. General Hospital, Palembang, Indonesia

Abstract

Reversal reaction in leprosy is an immunologically mediated response due to alteration of cell-mediated immunity associated in leprosy spectrum. In COVID-19 pandemic era, leprosy patient is susceptible to the infection. According to guideline, vaccination should be given to leprosy patients. This case reported a 33-year-old male with reversal reaction after COVID-19 vaccination. On examination, patient had erythematous plaque of the face, trunk and extremities, also multiple ulcers of the trunk and extremities. Treatment was commenced immediately with prednisone and second vaccination was delayed. Within our follow-up, marked improvement were obtained after 6 weeks.

Downloads

Published

2022-08-27

How to Cite

1.
Fantoni OJJ. Reversal Reaction in A Borderline Lepromatous Leprosy Patient after COVID-19 Vaccine: Prevention or Risks?. J Pak Assoc Dermatol [Internet]. 2022Aug.27 [cited 2024May19];32(3):609-12. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/1953

Issue

Section

Case Reports